Conditional estimation of sensitivity and specificity from a phase 2 biomarker study allowing Early termination for futility

Margaret Sullivan Pepe, Ziding Feng, Gary Longton, Joseph Koopmeiners

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Abstract

Development of a disease screening biomarker involves several phases. In phase 2 its sensitivity and specificity is compared with established thresholds for minimally acceptable performance. Since we anticipate that most candidate markers will not prove to be useful and availability of specimens and funding is limited, early termination of a study is appropriate, if accumulating data indicate that the marker is inadequate. Yet, for markers that complete phase 2, we seek estimates of sensitivity and specificity to proceed with the design of subsequent phase 3 studies. We suggest early stopping criteria and estimation procedures that adjust for bias caused by the early termination option. An important aspect of our approach is to focus on properties of estimates conditional on reaching full study enrollment. We propose the conditional-UMVUE and contrast it with other estimates, including naïve estimators, the well-studied unconditional-UMVUE and the mean and median Whitehead-adjusted estimators. The conditional-UMVUE appears to be a very good choice.

Original languageEnglish (US)
Pages (from-to)762-779
Number of pages18
JournalStatistics in Medicine
Volume28
Issue number5
DOIs
StatePublished - Feb 28 2009

Keywords

  • Diagnostic test
  • Group sequential
  • Screening
  • True positive rate

Fingerprint Dive into the research topics of 'Conditional estimation of sensitivity and specificity from a phase 2 biomarker study allowing Early termination for futility'. Together they form a unique fingerprint.

Cite this